Arete Wealth Advisors’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $1.69M | Buy |
17,895
+543
| +3% | +$51.8K | 0.11% | 184 |
|
|
2026
Q2 | $1.47M | Buy |
17,352
+224
| +1% | +$18.1K | 0.1% | 190 |
|
|
2026
Q1 | $1.21M | Sell |
17,128
-1,425
| -8% | -$107K | 0.09% | 204 |
|
|
2025
Q4 | $1.46M | Buy |
18,553
+1,504
| +9% | +$119K | 0.1% | 199 |
|
|
2025
Q3 | $1.4M | Buy |
17,049
+627
| +4% | +$49.3K | 0.1% | 186 |
|
|
2025
Q2 | $1.32M | Buy |
16,422
+8
| +0% | +$617 | 0.09% | 214 |
|
|
2025
Q1 | $1.25M | Buy |
16,414
+1,642
| +11% | +$137K | 0.1% | 219 |
|
|
2024
Q4 | $1.21M | Buy |
14,772
+1,123
| +8% | +$93.4K | 0.09% | 225 |
|
|
2024
Q3 | $1.12M | Sell |
13,649
-218
| -2% | -$16.3K | 0.1% | 208 |
|
|
2024
Q2 | $972K | Sell |
13,867
-757
| -5% | -$54K | 0.08% | 240 |
|
|
2024
Q1 | $1.08M | Sell |
14,624
-979
| -6% | -$68.2K | 0.1% | 198 |
|
|
2023
Q4 | $1.01M | Sell |
15,603
-259
| -2% | -$16.2K | 0.08% | 250 |
|
|
2023
Q3 | $990K | Buy |
15,862
+793
| +5% | +$49.4K | 0.17% | 130 |
|
|
2023
Q2 | $852K | Sell |
15,069
-1,228
| -8% | -$68.1K | 0.08% | 240 |
|
|
2023
Q1 | $944K | Buy |
16,297
+1,666
| +11% | +$112K | 0.08% | 224 |
|
|
2022
Q4 | $1.06M | Buy |
14,631
+2,873
| +24% | +$206K | 0.09% | 188 |
|
|
2022
Q3 | $715K | Buy |
11,758
+1,531
| +15% | +$97.8K | 0.07% | 233 |
|
|
2022
Q2 | $642K | Buy |
10,227
+1,415
| +16% | +$93.7K | 0.06% | 202 |
|
|
2022
Q1 | $619K | Buy |
8,812
+480
| +6% | +$32.5K | 0.05% | 246 |
|
|
2021
Q4 | $527K | Buy |
8,332
+1,463
| +21% | +$91.8K | 0.04% | 277 |
|
|
2021
Q3 | $424K | Buy |
6,869
+925
| +16% | +$55.7K | 0.05% | 280 |
|
|
2021
Q2 | $344K | Buy |
5,944
+652
| +12% | +$41.3K | 0.05% | 247 |
|
|
2021
Q1 | $322K | Buy |
5,292
+897
| +20% | +$49.5K | 0.04% | 307 |
|
|
2020
Q4 | $206K | Buy |
+4,395
| New | +$190K | 0.03% | 377 |
|
|
2018
Q1 | – | Sell |
-11,681
| Closed | -$591K | – | 340 |
|
|
2017
Q4 | $591K | Sell |
11,681
-303
| -3% | -$16K | 0.19% | 145 |
|
|
2017
Q3 | $623K | Sell |
11,984
-255
| -2% | -$12.4K | 0.25% | 127 |
|
|
2017
Q2 | $599K | Sell |
12,239
-519
| -4% | -$24.1K | 0.27% | 102 |
|
|
2017
Q1 | $601K | Buy |
12,758
+2,432
| +24% | +$116K | 0.26% | 84 |
|
|
2016
Q4 | $496K | Buy |
+10,326
| New | +$474K | 0.23% | 92 |
|
Other funds holding MET
Arete Wealth Advisors's MET Position: Q3 2026 in Review
Arete Wealth Advisors increased its MetLife (MET) stake by 3.1% in Q3 2026, buying an estimated $51.8K and bringing the position to 17,895 shares worth $1.69M. The position accounts for 0.11% of the portfolio, ranked #184.
Arete Wealth Advisors first reported a position in MET in Q4 2016 and has held it in 29 quarters since. 1,309 funds tracked by Wall St. Rank hold MET as of Q3 2026.
- Arete Wealth Advisors held 17,895 shares of MetLife worth $1.69M as of Q3 2026.
- Arete Wealth Advisors bought 543 MetLife shares in Q3 2026, an estimated $51.8K.
- MetLife made up 0.11% of Arete Wealth Advisors's portfolio in Q3 2026, its #184 holding.
- Arete Wealth Advisors first reported a position in MetLife in Q4 2016 and has held it in 29 quarters since.
- 1,309 funds tracked by Wall St. Rank held MetLife as of Q3 2026.
Based on Arete Wealth Advisors's 13F filing for Q3 2026, filed 9 Nov 2026.